Predicting Significance of Blood Parameters in Diagnosis of Prostate Carcinoma in a Tertiary Center in Udaipur, Rajasthan.

Introduction: In development of cancer chronic inflammation plays a major role. Most established determinants of Prostate Carcinoma (PCa) are modern life style genetics, and age. In the first prostate biopsy, approximately 1 out 5 men i.e., 20% with PCa may be misdiagnosed. Therefore, there is clear requirement of novel markers, which can detect both clinically significant PCa, and prevent unnecessary biopsy. Some solid tumours found to have association of Neutrophil to Lymphocyte Ratio (NLR), Platelate to Lymphocyte Ratio (PLR) and Red-cell Distribution Width (RDW). Aim: Aim of this study was to scrutinise the significance of association of Prostate Specific Antigen (PSA), PLR, NLR and RDW with PCa. Materials and Methods: This study was conducted using the cross-sectional method in the Department of Pathology, Geetanjali Medical College and Hospital, Udaipur, Rajasthan between Jan 2018 to Nov 2020. In this cross-sectional study 84 patients who underwent Tran Rectal Ultrasound (TRUS) guided were included. Complete Blood Count (CBC) was used to determine PLR, NLR and RDW and biochemical test for PSA. Patients were divided into two groups; having benign and malignant pathology. Unpaired t-test, Mann-whitney U test, logistic regression analysis and correlation were performed for statistical analysis. Results: With the use of univariate logistic regression, association between PSA, NLR, PLR, RDW values and PCa detection was determined. We found that serum PSA was significantly more in the PCa group (as BPH and prostatitis are both benign conditions so are kept in nonPCa group) compared to other two groups (p<0.001). There was no statistically significant difference in NLR, PLR and RDW values (p=0.150, p=0.070. p=0.441, respectively was found in nonPCa and PCa group). Conclusion: PSA has statistically significant association with PCa group but PLR, NLR and RDW was not considered to be the significant predictor in benign as well as malignant group. [ABSTRACT FROM AUTHOR]